These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11668819)

  • 1. FDA questions San Francisco HIV/AIDS drug advertisements.
    AIDS Policy Law; 2001 May; 16(9):1, 6. PubMed ID: 11668819
    [No Abstract]   [Full Text] [Related]  

  • 2. Advertisements. FDA orders Abbott to change misleading ads for Norvir.
    AIDS Policy Law; 2004 Jul; 19(12):9. PubMed ID: 15282864
    [No Abstract]   [Full Text] [Related]  

  • 3. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA tightens rules on advertising.
    Josefson D
    BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA investigates direct to consumer adverts.
    Lenzer J
    BMJ; 2005 Nov; 331(7525):1102. PubMed ID: 16282396
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 8. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
    Waxman HA
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-256-8. PubMed ID: 15452002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives. New twist on guideline dissemination stirs professional debate, gets slap from FDA.
    Newman L
    Med Health; 1999 Feb; 53(8):suppl 1-4. PubMed ID: 10345551
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 11. The FDA's restrictions against prescription drug advertising: more hindrance than help.
    Lorman AJ
    Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942
    [No Abstract]   [Full Text] [Related]  

  • 12. Off label drug promotion.
    Body Posit; 1998 Oct; 11(10):11. PubMed ID: 11365909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major issues in marketing regulation.
    Pines WL
    Food Drug Law J; 1997; 52(3):297-302. PubMed ID: 10343028
    [No Abstract]   [Full Text] [Related]  

  • 14. US Congress to consider limits on DTCA.
    Guthrie P
    CMAJ; 2007 May; 176(10):1404. PubMed ID: 17485685
    [No Abstract]   [Full Text] [Related]  

  • 15. Advertising for AIDS drugs: it's everywhere lately, but is it helpful?
    Mirken B
    BETA; 1998 Jul; ():18-22. PubMed ID: 11365555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 17. San Francisco serosorting may explain odd HIV data. STDs have risen, but not new HIV infections.
    AIDS Alert; 2004 May; 19(5):55-6. PubMed ID: 15206356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
    Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

  • 20. US aims to tighten rules on direct-to-consumer drug ads.
    Vastag B
    Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.